7F: Nanomedicine for Targeted Drug Delivery - 2

This session will emphasize product development and translational nanomedicine, including but not limited to evaluation of product effectiveness in vivo in disease models, nanomedicine manufacturing, and nanomedicine quality control for specific applications. Nanomedicines include colloids and other nanomaterials that have been engineered to target delivery of diverse payloads (such as small molecules, nucleic acids, or biologics) to specific cells or tissues. Targeting approaches may include but are not restricted to cell membrane coating, surface modification, engineering of particle geometry, or engineering other biophysical parameters. Abstracts from academic researchers with translational products or devices are welcomed and abstracts from industry members are especially encouraged.